Author: McCreary, Erin K; Pogue, Jason M
Title: Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options Document date: 2020_3_23
ID: j0i9ozsz_52
Snippet: Favipiravir RNA-dependent RNA polymerase inhibitor with broad-spectrum antiviral activity; however, demonstrated high EC 50 (decreased potency) against SARS-CoV-2 but was effective in protecting mice against Ebola virus despite similarly high EC 50 values [3] . Currently being evaluated in Clinical Trial NCT04273763 for patients with COVID-19. This agent is not FDA approved or available in the United States......
Document: Favipiravir RNA-dependent RNA polymerase inhibitor with broad-spectrum antiviral activity; however, demonstrated high EC 50 (decreased potency) against SARS-CoV-2 but was effective in protecting mice against Ebola virus despite similarly high EC 50 values [3] . Currently being evaluated in Clinical Trial NCT04273763 for patients with COVID-19. This agent is not FDA approved or available in the United States.
Search related documents:
Co phrase search for related documents- antiviral activity and broad spectrum antiviral activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antiviral activity and decrease potency: 1
- antiviral activity and Ebola virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antiviral activity and Ebola virus mouse: 1
- antiviral activity and RNA polymerase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antiviral activity and RNA polymerase inhibitor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- broad spectrum and Ebola virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- broad spectrum and RNA polymerase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- broad spectrum and RNA polymerase inhibitor: 1, 2, 3, 4, 5, 6, 7
- broad spectrum antiviral activity and Ebola virus: 1, 2, 3, 4, 5, 6, 7
- broad spectrum antiviral activity and RNA polymerase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- broad spectrum antiviral activity and RNA polymerase inhibitor: 1, 2, 3
- decrease potency and RNA polymerase: 1
- Ebola virus and RNA polymerase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- Ebola virus and RNA polymerase inhibitor: 1, 2, 3, 4, 5
- Ebola virus mouse and RNA polymerase: 1
Co phrase search for related documents, hyperlinks ordered by date